Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Earlitec Diagnostics announced it raised $3.5 Million in an initial filing from an offering of $7 Million
PRIVATEApr 30, 2026•4 months ago
Amount Raised
$3.5 Million
Round Type
Seed
AtlantaHealth CareEducation
Company Information
Company
Earlitec Diagnostics
Location
Atlanta, Georgia, United States
About
EarliTec Diagnostics is a digital health company making earlier identification and treatment for ASD and related disabilities accessible to children everywhere. Developed by leading researchers at Children’s Healthcare of Atlanta, Emory University School of Medicine and Yale University, EarliTec is pioneering development of biomarkers that help parents, providers and caregivers understand how a child is viewing the world. The company’s initial product, the EarliPoint® Evaluation for Autism Spectrum Disorder received breakthrough status from the FDA as it seeks to be the first objective, clinically validated measure of individual ASD status and severity in children as young as 16 months of age.
Don't miss Earlitec Diagnostics's next move
Get an email the moment Earlitec Diagnostics raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for Earlitec Diagnostics's next move
Atlanta